Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
6.46
-0.28 (-4.09%)
Aug 8, 2025, 2:30 PM - Market open

Paramount Global Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.7821.9415.535.574.63
Short-Term Investments
154.7182.82109.6641.6764.37
Cash & Short-Term Investments
175.48204.76125.1947.2469
Cash Growth
-19.74%63.56%165.01%-31.54%-
Prepaid Expenses
1.361.632.521.150.78
Total Current Assets
176.84206.39127.7148.3969.78
Property, Plant & Equipment
5.866.461.42.120.64
Other Long-Term Assets
0.1901.280.130.1
Total Assets
182.89212.85130.3950.6470.52
Accounts Payable
21.810.640.430.66
Accrued Expenses
3.756.714.392.061.69
Current Portion of Long-Term Debt
---3.951.25
Current Portion of Leases
1.471.450.461.11-
Other Current Liabilities
----0.08
Total Current Liabilities
7.219.975.487.553.67
Long-Term Debt
----3.66
Long-Term Leases
4.284.810.110.79-
Other Long-Term Liabilities
--0.113.031.6
Total Liabilities
11.514.785.711.378.93
Common Stock
0.030.0300.010.01
Additional Paid-In Capital
320.65315.377.14.722.74
Retained Earnings
-149.43-117.4-75.14-97.86-73.61
Comprehensive Income & Other
0.150.070.11-0.08-0.04
Total Common Equity
171.39198.07-67.94-93.21-70.89
Shareholders' Equity
171.39198.07124.6839.2761.59
Total Liabilities & Equity
182.89212.85130.3950.6470.52
Total Debt
5.756.260.575.854.91
Net Cash (Debt)
169.73198.5124.6241.3964.1
Net Cash Growth
-22.16%59.29%201.08%-35.42%-
Net Cash Per Share
6.5610.2636.7018.4530.39
Filing Date Shares Outstanding
28.0425.872.352.262.11
Total Common Shares Outstanding
25.9225.852.352.262.11
Working Capital
169.63196.41122.2240.8466.11
Book Value Per Share
6.617.66-28.91-41.25-33.61
Tangible Book Value
171.39198.07-67.94-93.21-70.89
Tangible Book Value Per Share
6.617.66-28.91-41.25-33.61
Machinery
-2.532.111.691.58
Leasehold Improvements
-0.180.050.020.02
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q